Literature DB >> 9698474

Hepatic metastases from carcinoma of the uterine cervix.

G E Kim1, S W Lee, C O Suh, T K Park, J W Kim, J T Park, J U Shim.   

Abstract

OBJECTIVE: To investigate the patterns of hepatic involvement and the outcome of patients with hepatic metastases from carcinoma of the uterine cervix.
METHODS: Of 1665 patients with carcinoma of the uterine cervix, 20 patients with hepatic metastases were detected clinically during the course of the disease. Clinical presentation and detailed patterns of hepatic involvement were retrospectively reviewed for these patients. Comparative analysis between patterns of heaptic metastases and survival data was also undertaken.
RESULTS: Hepatic metastasis from carcinoma of the uterine cervix were nearly always accompanied by uncontrolled locoregional diseases and/or extrahepatic metastases, whereas only 1 patient developed an isolated hepatic metastasis. Ninety percent of the hepatic metastases were metachronously detected. The median time from the appearance of primary carcinoma to detection of hepatic metastases was 39 months, but late metastases after 5 years were not uncommon. Metastatic lesion in 16 patients consisted of multiple tumors distributed in either one or both anatomical lobes, whereas only 4 patients had a solitary lesion confined to a single lobe. Patients with hepatic metastases were unlikely to survive 2 years with a median survival of 10 months.
CONCLUSION: Favorable patterns of hepatic metastases in patient with carcinoma of the uterine cervix were not major determinants of favorable survival if components of extrahepatic disease were concomitantly present.

Entities:  

Mesh:

Year:  1998        PMID: 9698474     DOI: 10.1006/gyno.1998.5037

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Surgical resection of recurrent upper abdominal cervical cancer: A case report and review of the literature.

Authors:  Andrea Papadia; Yesenia Moya; Steven E Rodgers; Joseph A Lucci; John P Diaz
Journal:  Gynecol Oncol Case Rep       Date:  2011-10-06

Review 2.  Locoregional Therapies for the Treatment of Hepatic Metastases from Breast and Gynecologic Cancers.

Authors:  Samdeep K Mouli; Ramona Gupta; Neil Sheth; Andrew C Gordon; Robert J Lewandowski
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

3.  Establishment of red fluorescent protein-tagged HeLa tumor metastasis models: determination of DsRed2 insertion effects and comparison of metastatic patterns after subcutaneous, intraperitoneal, or intravenous injection.

Authors:  Jau-Yeong Lu; Hui-Chun Chen; Ricky Yuan-Yuan Chu; Tsu-Chun Emma Lin; Ping-I Hsu; Ming-Shyan Huang; Ching-Jiunn Tseng; Michael Hsiao
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

4.  Hepatic pseudocyst as the first presentation of squamous cell carcinoma of uterine cervix.

Authors:  Mohammad M Alsolaiman; Richard P MacDermott; Catherine Bartholomew
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

5.  Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.

Authors:  Austin B Gardner; Lindsey M Charo; Amandeep K Mann; Daniel S Kapp; Ramez N Eskander; John K Chan
Journal:  Clin Exp Metastasis       Date:  2019-11-22       Impact factor: 5.150

Review 6.  Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review.

Authors:  Neville F Hacker; Archana Rao
Journal:  Gynecol Oncol Res Pract       Date:  2016-06-17

7.  Case report of hepatic pseudocyst: A rare manifestation of liver metastasis from an anal squamous cell carcinoma.

Authors:  Tomoaki Bekki; Yuji Takakura; Masatoshi Kochi; Kei Kushitani; Keiichi Mori; Koji Arihiro; Yoshifumi Teraoka; Hiroyuki Egi; Hideki Ohdan
Journal:  Int J Surg Case Rep       Date:  2019-08-17

8.  Incidence, clinical risk and prognostic factors for liver metastasis in patients with cervical cancer: a population-based retrospective study.

Authors:  Hang Liu; Xiangsen Ye; Di Li; Qian Yao; Yan Li
Journal:  BMC Cancer       Date:  2021-04-16       Impact factor: 4.430

Review 9.  Defining the role of high-dose radiation in oligometastatic & oligorecurrent cervical cancer.

Authors:  Akshay Mangaj; Supriya Chopra; Remi A Nout
Journal:  Indian J Med Res       Date:  2021-08       Impact factor: 5.274

10.  Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer.

Authors:  Zhuomin Yin; Huarong Tang; Li Li; Juan Ni; Shuhui Yuan; Hanmei Lou; Ming Chen
Journal:  Cancer Manag Res       Date:  2019-08-16       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.